Tunlametinib

Tunlametinib 구조식 이미지
카스 번호:
1801756-06-8
상품명:
Tunlametinib
동의어(영문):
Tunlametinib;Tunlametinib(HL-085);6-Benzothiazolecarboxamide, 4-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)-;4-Fluoro-5-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)benzo[d]thiazole-6-carboxamide
CBNumber:
CB39789435
분자식:
C16H12F2IN3O3S
포뮬러 무게:
491.25
MOL 파일:
1801756-06-8.mol

Tunlametinib 속성

밀도
1.864±0.06 g/cm3(Predicted)
물리적 상태
Solid
산도 계수 (pKa)
14.17±0.10(Predicted)
색상
Off-white to light yellow

안전

Tunlametinib C화학적 특성, 용도, 생산

개요

Tunlametinib is a selective mitogen-activated protein kinase 1 and kinase 2 (MEK1/2) kinase inhibitor, which plays an antitumor role by inhibiting the activity of MEK1/2 kinase. The marketing of this drug provides new treatment options for patients with advanced NRAS-mutant melanoma who fail anti- PD-1/PD-L1 therapy.

제조 방법

synthesis of Tunlametinib

Tunlametinib 준비 용품 및 원자재

원자재

준비 용품


Tunlametinib 공급 업체

글로벌( 10)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Soochow Chirally Material Science and Technology Co.,Ltd
+86-51266834346 +86-17751128648
sales@krl-tech.com China 942 58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. 17702719238 18971495150;
sales@sun-shinechem.com China 1077 64
Changzhou Chenhong Biotechnology Co., Ltd. +86-0519-85788828 +86-13775037613
sales@chemrenpharm.com China 3934 58
ShangHai ChuanQian Chemcial Technique Centre 15869524721
3525679403@qq.com China 4989 58
Chunchuang (Wuhan) Technology Co., Ltd 15727060112
yutianchun2007@126.com China 9804 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
sales@chemhifuture.com China 5929 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-025-66113011 18626450290
cb5@aikonchem.com China 10358 58
Soochow Chirally Material Science and Technology Co.,Ltd 0512-66834346 17751187418
sales@krl-tech.com China 1092 58
Shaoyuan Technology (Shanghai) Co., Ltd. 021-50795510 4000665055
sy-c6@accelachem.com China 10000 58
Shanghai Weijiahe Biotechnology Co., Ltd 17502176150
861873257@qq.com China 1653 58

Copyright 2019 © ChemicalBook. All rights reserved